Kinetics and risk factors of relapse after allogeneic stem cell transplantation in children with leukemia: A long-term follow-up single center study

Nowadays, allogeneic hematopoietic stem cell transplantation (allo-HSCT) is considered an established treatment for pediatric patients with high-risk hematological malignancies. Relapse after transplantation still remains the leading cause of death after transplantation1,2 especially in recent years once transplant related mortality has reduced thanks to improved supportive care.

Source: Biology of Blood and Marrow Transplantation - August 22, 2018 Category: Hematology Authors: Blanca Molina, Marta Gonzalez Vicent, Madrid Blanca Herrero, Madrid Natalia Deltoro, Madrid Julia Ruiz, Madrid Miguel A Diaz, Madrid Antonio Perez Source Type: research